Dirk L. Teagarden

1.4k total citations · 1 hit paper
16 papers, 1.1k citations indexed

About

Dirk L. Teagarden is a scholar working on Molecular Biology, Organic Chemistry and Pharmaceutical Science. According to data from OpenAlex, Dirk L. Teagarden has authored 16 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pharmaceutical Science. Recurrent topics in Dirk L. Teagarden's work include Protein purification and stability (7 papers), Drug Solubulity and Delivery Systems (3 papers) and Chemical and Physical Properties in Aqueous Solutions (2 papers). Dirk L. Teagarden is often cited by papers focused on Protein purification and stability (7 papers), Drug Solubulity and Delivery Systems (3 papers) and Chemical and Physical Properties in Aqueous Solutions (2 papers). Dirk L. Teagarden collaborates with scholars based in United States, United Kingdom and China. Dirk L. Teagarden's co-authors include Wei Wang, Sandeep Nema, David S. Baker, Joe L. White, Stanley L. Hem, Bradley D. Anderson, John F. Kozlowski, Bakul Bhatnagar, Evgenyi Shalaev and Raj Suryanarayanan and has published in prestigious journals such as Advanced Drug Delivery Reviews, Physical Chemistry Chemical Physics and International Journal of Pharmaceutics.

In The Last Decade

Dirk L. Teagarden

16 papers receiving 1.1k citations

Hit Papers

Protein aggregation—Pathways and influencing factors 2010 2026 2015 2020 2010 200 400 600
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. Protein aggregation—Pathways and influencing factors
    2010 630 citations Wei Wang, Sandeep Nema et al. International Journal of Pharmaceutics profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Dirk L. Teagarden United States 13 648 205 182 165 149 16 1.1k
Michael J. Akers United States 16 627 1.0× 150 0.7× 344 1.9× 207 1.3× 183 1.2× 50 1.2k
Henry A. Havel United States 21 650 1.0× 74 0.4× 81 0.4× 86 0.5× 276 1.9× 36 1.3k
Chikako Yomota Japan 18 358 0.6× 38 0.2× 256 1.4× 167 1.0× 122 0.8× 80 1.0k
Roudayna Diab France 13 339 0.5× 105 0.5× 230 1.3× 139 0.8× 192 1.3× 16 1.1k
Mariano Grasselli Argentina 20 453 0.7× 90 0.4× 40 0.2× 77 0.5× 147 1.0× 82 1.1k
Enam A. Khalil Jordan 25 297 0.5× 173 0.8× 319 1.8× 182 1.1× 267 1.8× 62 1.7k
Weiguo Dai United States 20 505 0.8× 153 0.7× 897 4.9× 89 0.5× 428 2.9× 23 1.6k
Andrew Lyddiatt United Kingdom 26 937 1.4× 132 0.6× 30 0.2× 115 0.7× 446 3.0× 97 1.9k
Shuji Noguchi Japan 20 457 0.7× 36 0.2× 355 2.0× 92 0.6× 340 2.3× 97 1.2k

Countries citing papers authored by Dirk L. Teagarden

Since Specialization
Citations

This map shows the geographic impact of Dirk L. Teagarden's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dirk L. Teagarden with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dirk L. Teagarden more than expected).

Fields of papers citing papers by Dirk L. Teagarden

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dirk L. Teagarden. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dirk L. Teagarden. The network helps show where Dirk L. Teagarden may publish in the future.

Co-authorship network of co-authors of Dirk L. Teagarden

This figure shows the co-authorship network connecting the top 25 collaborators of Dirk L. Teagarden. A scholar is included among the top collaborators of Dirk L. Teagarden based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dirk L. Teagarden. Dirk L. Teagarden is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Bhatnagar, Bakul, et al.. (2020). A refined phase diagram of the tert-butanol–water system and implications on lyophilization process optimization of pharmaceuticals. Physical Chemistry Chemical Physics. 22(3). 1583–1590. 21 indexed citations
2.
Bhatnagar, Bakul, et al.. (2011). Investigation of PEG Crystallization in Frozen and Freeze‐Dried PEGylated Recombinant Human Growth Hormone–Sucrose Systems: Implications on Storage Stability. Journal of Pharmaceutical Sciences. 100(8). 3062–3075. 14 indexed citations
3.
Bhatnagar, Bakul, et al.. (2010). Investigation of PEG Crystallization in Frozen PEG–Sucrose–Water Solutions: II. Characterization of the Equilibrium Behavior During Freeze-Thawing. Journal of Pharmaceutical Sciences. 99(11). 4510–4524. 19 indexed citations
4.
Wang, Wei, Sandeep Nema, & Dirk L. Teagarden. (2010). Protein aggregation—Pathways and influencing factors. International Journal of Pharmaceutics. 390(2). 89–99. 630 indexed citations breakdown →
5.
6.
Bhatnagar, Bakul, et al.. (2010). Investigation of PEG Crystallization in Frozen PEG-Sucrose-Water Solutions. I. Characterization of the Nonequilibrium Behavior during Freeze-Thawing. Journal of Pharmaceutical Sciences. 99(6). 2609–2619. 11 indexed citations
7.
Zhang, Bo, Dirk L. Teagarden, Christian Schöneich, et al.. (2010). Comparative Evaluation of Disodium Edetate and Diethylenetriaminepentaacetic Acid as Iron Chelators to Prevent Metal -Catalyzed Destabilization of a Therapeutic Monoclonal Antibody. Journal of Pharmaceutical Sciences. 99(10). 4239–4250. 46 indexed citations
8.
Ramstad, Tore, et al.. (2005). Determination by NMR of the binding constant for the molecular complex between alprostadil and α-cyclodextrinImplications for a freeze-dried formulation. International Journal of Pharmaceutics. 296(1-2). 55–63. 24 indexed citations
9.
Teagarden, Dirk L. & David S. Baker. (2002). Practical aspects of lyophilization using non-aqueous co-solvent systems. European Journal of Pharmaceutical Sciences. 15(2). 115–133. 155 indexed citations
10.
Teagarden, Dirk L., et al.. (1996). The distribution and chemical kinetics of prostaglandin E1 in lipid emulsions. Advanced Drug Delivery Reviews. 20(2-3). 155–164. 12 indexed citations
11.
Teagarden, Dirk L., et al.. (1989). Dehydration kinetics of prostaglandin E1 in a lipid emulsion.. Pharmaceutical Research. 6(3). 210–215. 18 indexed citations
12.
Teagarden, Dirk L., et al.. (1988). Determination of the pH-Dependent Phase Distribution of Prostaglandin El in a Lipid Emulsion by Ultrafiltration. Pharmaceutical Research. 5(8). 482–487. 32 indexed citations
13.
Teagarden, Dirk L., Stanley L. Hem, & Joe L. White. (1982). Conversion of aluminum chlorohydrate to aluminum hydroxide. 7 indexed citations
14.
Teagarden, Dirk L., Stanley L. Hem, J.F. Radavich, & Joe L. White. (1981). Aluminum chlorohydrate II: Physicochemical properties. Journal of Pharmaceutical Sciences. 70(7). 762–764. 15 indexed citations
15.
Teagarden, Dirk L., Stanley L. Hem, John F. Kozlowski, & Joe L. White. (1981). Aluminum chlorohydrate I: Structure studies. Journal of Pharmaceutical Sciences. 70(7). 758–761. 66 indexed citations
16.
Teagarden, Dirk L., Joe L. White, & Stanley L. Hem. (1981). Aluminum chlorohydrate III: Conversion to aluminum hydroxide. Journal of Pharmaceutical Sciences. 70(7). 808–810. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Michael J. Akers Breakdown of academic impact, for papers by Henry A. Havel Breakdown of academic impact, for papers by Chikako Yomota Breakdown of academic impact, for papers by Roudayna Diab Breakdown of academic impact, for papers by Mariano Grasselli Breakdown of academic impact, for papers by Enam A. Khalil Breakdown of academic impact, for papers by Weiguo Dai Breakdown of academic impact, for papers by Andrew Lyddiatt Breakdown of academic impact, for papers by Shuji Noguchi
Rankless by CCL
2026